Sonnet BioTherapeutics Holdings's market cap is currently $35.02M. The company's EPS TTM is $-0.92; its P/E ratio is ―; Sonnet BioTherapeutics Holdings is scheduled to report earnings on May 20, 2025, and the estimated EPS forecast is $-0.49. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Currency in USD
Sonnet BioTherapeutics Holdings Earnings and Revenue History
